TheraRadar

Pharma Intelligence, Simplified

Company Portfolios →

Gilead

60 active trials across 7 therapeutic areas

60
Active Trials
16
Phase 1
27
Phase 2
25
Phase 3
7
Therapeutic Areas

Oncology

29 active / 75 total
Solid Tumor (Advanced)
10 active
18 total since 2015
Triple Negative Breast Cancer
6 active 3 Ph3
8 total since 2015
NSCLC
4 active 2 Ph3
4 total since 2015
Breast Cancer
3 active 2 Ph3
5 total since 2015
Bladder Cancer
2 active
3 total since 2015
Head and Neck Cancer
1 active
2 total since 2015
SCLC
1 active 1 Ph3
1 total since 2015
Lung Cancer (General)
1 active
1 total since 2015
Endometrial Cancer
1 active 1 Ph3
1 total since 2015
Non-Hodgkin Lymphoma
0 active
6 total since 2015
AML
0 active
5 total since 2015
CLL
0 active
5 total since 2015
Gastric Cancer
0 active
3 total since 2015
Colorectal Cancer
0 active
2 total since 2015
MDS
0 active
2 total since 2015
Hodgkin Lymphoma
0 active
1 total since 2015
Multiple Myeloma
0 active
1 total since 2015
Ovarian Cancer
0 active
1 total since 2015
Pancreatic Cancer
0 active
1 total since 2015
Prostate Cancer
0 active
1 total since 2015
Myelofibrosis
0 active
1 total since 2015
Hematologic Malignancies
0 active
1 total since 2015
ALL
0 active
1 total since 2015
HER2- Breast Cancer
0 active
1 total since 2015

Infectious Disease

23 active / 120 total
HIV
22 active 13 Ph3
54 total since 2015
Hepatitis B
1 active
13 total since 2015
Hepatitis C
0 active
39 total since 2015
COVID-19
0 active
9 total since 2015
RSV
0 active
5 total since 2015

Immunology

5 active / 33 total
Rheumatoid Arthritis
2 active
14 total since 2015
Ulcerative Colitis
2 active
5 total since 2015
Ankylosing Spondylitis
1 active
5 total since 2015
Lupus
0 active
4 total since 2015
Crohn's Disease
0 active
3 total since 2015
Psoriatic Arthritis
0 active
2 total since 2015

Hepatology

2 active / 6 total
Cirrhosis
1 active 1 Ph3
5 total since 2015
Liver Failure
1 active
1 total since 2015

Metabolic

0 active / 16 total
NASH/NAFLD
0 active
13 total since 2015
Diabetic Complications
0 active
2 total since 2015
Dyslipidemia
0 active
1 total since 2015

Cardiovascular

0 active / 3 total
Atrial Fibrillation
0 active
1 total since 2015
Hypertrophic Cardiomyopathy
0 active
1 total since 2015
Myocardial Infarction
0 active
1 total since 2015

Respiratory

0 active / 2 total
Cystic Fibrosis
0 active
2 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)